Shandong Boan Biotechnology Company., Limited. Class H (HK:6955)
:6955
Comparison Results
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.15
HK$4.45B
558.59
-12.59%
―
Alphamab Oncology
HK$9.39
HK$9.15B
-76.25
58.35%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$17.95
HK$19.05B
-9.33
272.41%
2 Buy
1 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$12.61B
5.89
120.25%
1 Buy
0 Hold
0 Sell
Moderate Buy
Abbisko Cayman Limited
HK$13.02
HK$9.01B
135.64
103.53%
3 Buy
0 Hold
0 Sell
Strong Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$24.51B
42.36
384.65%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
7.15
-1.13
-13.65%
HK:9966
Alphamab Oncology
9.39
2.74
41.20%
HK:1672
Ascletis Pharma, Inc.
17.95
12.18
211.09%
HK:2142
HBM Holdings Ltd.
14.25
6.48
83.40%
HK:2256
Abbisko Cayman Limited
13.25
6.05
84.03%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
60.00
47.72
388.60%